E-Qure Corp. (EQUR) Research

E-Qure Corp., a medical technology firm, is dedicated to the development and distribution of medical devices that utilize bioelectrical signal therapy (BST). These BST devices leverage their exclusive and patented electrical stimulation techniques to address and resolve challenging, difficult-to-heal wounds and ulcers, aiming for their full closure and recovery. The company was founded in 1988 and operates from its headquarters in New York, New York.

Market snapshot

Symbol
EQUR
Price
$0.00
Day change
-99.50%
Market cap
$6.9K
P/E ratio
-0.01x
52-week range
2.0E-4-0.0499
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • American Bio Medica Corporation (ABMC)
  • Acacia Diversified Holdings, Inc. (ACCA)
  • Allied Healthcare Products, Inc. (AHPIQ)
  • Gene Biotherapeutics, Inc. (CRXM)
  • Capha Pharmaceuticals Inc. (FPSUF)
  • Gelesis Holdings, Inc. (GLSHQ)
  • EastWest Bioscience Inc. (HBOSF)
  • MobileSmith, Inc. (MOSTQ)

Recent insider activity

  • WEISSBERG RON — S-Sale (62380 shares) on 2014-05-22

Open E-Qure Corp. (EQUR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.